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bstract
Heavy-ion beams have unique biophysical and radiobiological properties, such as the inverted depth dose profile compared to
hoton beams, relative biological effectiveness and oxygen enhancement ratio. These physical and biological properties are much
ore favourable than those of photon radiotherapy and can be used to treat tumours efficiently. During a long-term stay in space,
stronauts will be constantly exposed to low-dose space radiation. Thus, space radiation is one of the major health-related concerns
or space exploration. This review summarizes the biophysical and biological properties of charged particles and their advantage in
adiotherapy. In addition, we briefly reviewed the importance of the heavy ion during space flight and how to suppress its deleterious
ffects.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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.  Introduction
The principle aim of radiation biophysics is to relate
hysical properties to observed biological responses to
adiations of different qualities and their implications in
adiation therapy and radiation protection [1]. The use of
roton and heavy ion irradiation in cancer therapy was
roposed due to their biophysical and biological superi-
rity compared with photon beams [2]. R. Wilson, from
erkeley, analyzed the depth dose profile of protons and
roposed their use in 1946. In 1954, Tobias, Lawrence∗ Corresponding author. Tel.: +202 22747413.
E-mail address: omardesouky@yahoo.com (O. Desouky).
eer review under responsibility of Taibah University.
ttp://dx.doi.org/10.1016/j.jtusci.2015.02.014
658-3655 © 2015 The Authors. Production and hosting by Elsevier B.V. on 
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).and space mission
and Larson began to treat patients with protons and, later
on, with He (helium) ions [3]. Now, interest in the bio-
logical effects of heavy ions is rapidly growing in the
scientific community. Heavy charged particles represent
the best tool for an external radiotherapy due to their
favourable depth dose distribution, i.e., where the dose
increases with penetration depth, allowing irradiation
of deep-seated target volumes with optimum precision.
Recent results of heavy-ion cancer therapy in Japan and
Germany [4] have stimulated the construction of several
accelerator facilities for particle therapy.
On the other hand, the greater RBE (relative biologi-
cal effectiveness) of heavy ion particles is the concern of
space-radioprotection because the radiation spectrum of
the galactic cosmic radiation (GCR) consists of heavy
charged particles, from protons to iron ions. Astro-behalf of Taibah University. This is an open access article under the
nauts and cosmonauts aboard Low Earth Orbit (LEO)
spacecraft, such as the NASA Space Shuttle and the
International Space Station (ISS), or aboard spacecraft
ah Univ
dose delivered to the tumour using a single beam is gen-
erally lower than the dose to the normal tissue in front
of the tumour [12].188 O. Desouky, G. Zhou / Journal of Taib
travelling outside the Earth’s magnetosphere on missions
to and from the Moon or Mars are exposed to levels of
ionizing radiation far in excess of those encountered on
the ground [5]. The levels of ionizing radiation in deep
space are far in excess to levels on the ground, and crew
members could be exposed to GCRs at a dose rate of
≈1 mSv/day, compared to an average ≈10 Sv/day on
Earth. Moreover, SPEs ranging from less than an hour
to several weeks can cause lethal dose rates 100 times
higher than those of GCRs. Therefore, space radiation
is one of the major health-related concerns for manned
space exploration [6].
The radiation environment in space is a complex mix-
ture of particles of solar and galactic origin with a broad
range of energies. For radiological protection, the rele-
vant radiation fields are galactic cosmic radiation (GCR),
particles ejected from the Sun during solar particle events
(SPE) and secondary radiation produced through inter-
action with the planet’s atmospheric nuclei [7].
The distribution of GCRs is believed to be isotropic
throughout interstellar space and consists mainly of pro-
tons and ions with energies up to several hundred GeV,
with their peaks ranging from several hundred MeV
to approximately 1 GeV. The GCRs consist of approxi-
mately 98% hadrons and approximately 2% leptons (e+
and e−), and the hadron component consists of approx-
imately 87% protons, 12%   particles and 1% heavy
ions [8]. In the case of ISS, the GCRs contribute approx-
imately 50% of the total dose equivalent rate received
by astronauts/cosmonauts. SPE are predominantly com-
posed of protons, electrons and an even smaller part
of heavy ions. Geomagnetically trapped particles con-
sist of protons and electrons, which are trapped in the
geomagnetic field layer [9].
2.  LET  (linear  energy  transfer)  and  stopping
power
HZE (High charge and energy) particles create ion-
ization immediately and continuously as they penetrate
matter. Because of their large mass, they travel in straight
trajectories with a relatively well defined stopping point
or range. The pattern of HZE energy deposition is char-
acterized by a dense core of ionization that is localized
along the trajectory of the particle [10]. LET reflects the
rate at which ionization is produced along the track of
charged particles and has dimensions of energy per unit
length (e.g., keV/m).X-ray and -ray photons deposit energy in tissue in
a highly dispersed manner, characterized as low LET.
Linear energy transfer (LET) is the major parameter that
characterizes radiation in this field. Also referred to asersity for Science 10 (2016) 187–194
stopping power, LET represents the mean amount of
energy an incident particle transfers to the target medium
per unit path length. IR (ionizing radiation) can either be
low LET (sparsely ionizing) or high LET (densely ion-
izing). Photons are low LET radiation, displaying a very
broad energy distribution in tissue, and the peak dose is
located relatively close to the surface [10] (Fig. 1).
Electrons have sparse ionizations along the track
(0.2 keV/m) and are classified as low LET radiation.
This classification also applies to photons that produce
sparsely ionizing electrons, whereas HZE particles can
have a LET > 100 keV/m and are classified as high LET
radiations [11].
3.  Depth  dose  distribution  (Bragg  peak)
In Fig. 1, the depth dose profile of electromagnetic
radiation is compared to that of carbon ions. For low-
energy X-rays, the stochastic absorption by photoelectric
and Compton scattering yield an exponential decay
of absorbed dose with penetration. For greater photon
energies, the produced Compton electrons are strongly
forwardly scattered and transport some of the transferred
energy from the surface to greater depths, yielding an
increase in dose in the first few centimetres. For photon
beams produced as electron Bremsstrahlung in clini-
cal linacs, there is an increase of the dose distribution
within the first few centimetres (‘build up’), and after
the maximum, the dose drops essentially according to
an exponential law. Thus, for deep seated tumours, theFig. 1. Comparison of the depth dose profiles of high energetic photons
and protons. Protons show the characteristic inverse depth dose profile
(Bragg peak).
Modified from Ref. [10].














































Fig. 2. Definition of relative biological effectiveness (RBE), illustrated
for cell survival curves.
the presence or absence of molecular oxygen within a
cell influences the biological effects of ionizing radia-
tion. Oxygenated tissues are more sensitive to low LETO. Desouky, G. Zhou / Journal of Taib
Because of their large mass, compared with electrons
nd photons, heavy charged particles travel in straight
rajectories as they penetrate tissue. High energy hadrons
ncident upon tissues begin to slow down from collisions
ith electrons in matter and release small amounts of
nergy along the track. This is referred to as the Bragg
lateau. As they approach the end of their range, they
egin to decelerate rapidly, depositing a large amount of
nergy in a very short distance (Fig. 1). This is referred to
s the Bragg peak, first described in 1907 [13]. Beyond
he Bragg peak, the energy deposition diminishes very
apidly, and thus tissue beyond the Bragg peak receives
ittle or no radiation dose. The inverse dose profile, i.e.,
he increase of energy deposition with penetration depth
p to a sharp maximum at the end of the particle range, is
he main reason to use heavy charged particles in tumour
herapy instead of photons [11].
Carbon ion beams in the energy range of approxi-
ately 100–450 MeV/u offer excellent conditions for
umour therapy, in particular for the treatment of
eep-seated, radio-resistant tumours. Their depth-dose
istribution is characterized by a low dose in the entrance
hannel, small lateral beam spread and an elevated bio-
ogical effectiveness in the Bragg peak region [14].
Clinical experiences have demonstrated that carbon
on radiotherapy is effective in such regions as the head
nd neck, skull base, lung, liver, prostate, bone and soft
issues, and pelvic recurrence of rectal cancer, as well as
or histological types, including adenocarcinoma, ade-
oid cystic carcinoma, malignant melanoma and various
ypes of sarcomas, against which photon therapy could
e less effective [15].
Therefore, the physical properties of charged particle
adiation provide several significant benefits in radiothe-
apy. First, the depth dose profile is inverted compared
o photon beams and they exhibit an increased biologi-
al effectiveness, in particular, at the end of their range
nd thus in the target volume. Second, there is little dam-
ge to surrounding normal tissue, particularly beyond the
istal boundary of the tumour, due to the rapid decrease
n energy deposition distal to the Bragg peak [16,17].
.  RBE  and  OER  (Oxygen  enhancement  ratio)
RBE compares the efficiency of different types of
adiation to produce a defined biological effect com-
ared to a reference photon radiation. It is defined as
 ratio of the dose of the reference radiation to that of the
est radiation required to yield the same biological end
oint, such as cell killing, DNA damage, and chromo-
ome aberrations [2,18]. The average RBE for protons
s 1.1 [19], while the average RBE for carbon ions isModified from Ref. [20].
much higher, estimated to be 2.5–3. Fig. 2 demonstrates
a schematic dose effect curve for cell inactivation for
particles compared to that of X-rays.
The RBE varies not only with the type of radiation
but also with the type of cell or tissue, biologic effect
under investigation, dose, dose rate and fractionation.
In general, the RBE increases with the LET to reach a
maximum RBE of 3–8 (depending on the level of cell
kill) at LET ∼  200 keV/m and then decreases because
of energy overkill, as shown in Fig. 3.
The majority of DNA damage by either high- or low-
LET radiation is thought to arise indirectly through the
production of reactive oxygen species (ROS). Therefore,Fig. 3. Curves of RBE and OER as functions of LET.
Modified from Ref. [21].
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Fig. 4. Effect of hypoxia upon cell SF and the definition of the oxygen-
doses. In the indirect action, the radiation hits the waterenhancement ratio (OER).
Modified from Ref. [21].
radiation, reflecting the requirement for ROS produc-
tion to damage DNA. Unfortunately, many tumours are
hypoxic, or have hypoxic regions, and show significant
radioresistance to low-LET radiation. Especially for
low-LET radiations, the larger the cell oxygenation
above anoxia, the larger the biological effects until sat-
uration of the effect of oxygen occurs. One measure of
this resistance is the “oxygen enhancement ratio” (OER).
OER is defined as the ratio of doses without and with
oxygen (hypoxic versus well oxygenated cells) to pro-
duce the same biological effect. The OER decreases as
the LET increases and approaches OER = 1 at approxi-
mately LET = 150 keV/m, as shown in Fig. 3.
For both photon and proton radiation, the OER is
∼3, meaning that hypoxic cells require three times the
dose as normoxic cells to achieve the same level of cell
killing. Importantly, carbon ions show a much lower
OER; thus, even hypoxic tumours show significant sen-
sitivity to high LET carbon ion radiation. This most
likely reflects the fact that the highly charged carbon
ions achieve dense ionization along the tracks even in
hypoxic conditions, resulting in a high level of clustered
DNA damage. Clustered DNA damages are difficult to
repair [22,23] (Fig. 4).
Although heavy ion beams and protons exhibit a sim-
ilar physical profile, carbon ions have a significantly
better biological effectiveness. For protons, the RBE is
elevated only at the last few micrometres of the ion’s
range. For carbon ions, the regime of increased RBE
extends over the last centimetres of range and coincides
with the dose elevation of the Bragg peak. Clinical pro-
ton beams in the range of 160–230 MeV are assumed to
have an overall clinical RBE of 1.1–1.2, while for the
heavier carbon ions, the RBE distribution in the target
volume varies between 2 and 5 [24].ersity for Science 10 (2016) 187–194
5.  Nuclear  fragmentation
Protons and carbon ions are classified as hadrons and
are thus capable of nuclear interactions. When heavy ions
pass through a thick absorber, such as the human body or
the thick shielding of a space craft, even small cross sec-
tions for nuclear reactions produce a significant amount
of lighter reaction products. The projectile fragments
have the same velocity as the original particle but reduced
mass and charge. This results in a mixture of particles
with different LETs passing through the tumour.
In radiotherapy, the change in biological efficiency
between the primary ions, e.g., carbon, and the lighter
secondaries has to be taken into account in treatment
planning. Currently, the only technically feasible method
for the evaluation of the delivered dose distribution is
based on tissue activation measurements by means of
positron emission tomography (PET) [25]. This makes
use of +-active nuclei (e.g., 10C, 11C, 13N and 15O)
produced in nuclear interactions of the therapeutic beam
with the tissue nuclei. This method has been shown to be
applicable for the monitoring of both proton and carbon
ion beams [26].
For space research, fragmentation represents a major
obstacle: to shield against the very numerous low energy
particles of a few hundred MeV, very efficient energy
absorbers are needed, in which the few high-energy par-
ticles produce showers of light low energy particles [27].
The process of nuclear fragmentation can play a key
role in reducing both the physical dose and biological
effectiveness of the radiation encountered in deep space.
Hydrogenous materials and light elements are expected
to be more effective shields against the deleterious effects
of galactic cosmic rays (GCR) than aluminium, which is
used in current spacecraft hulls [28].
6.  Direct  and  indirect  radiation  effect
Radiation damage to the cell can be caused by
the direct or indirect action of radiation on the DNA
molecules. In the direct action, the radiation hits the
DNA molecule directly, disrupting the molecular struc-
ture. Such structural change leads to cell damage or
even cell death. Damaged cells that survive may later
induce carcinogenesis or other abnormalities. This pro-
cess becomes predominant with high-LET radiations,
such as -particles and neutrons, and high radiationmolecules, the major constituent of the cell, and other
organic molecules in the cell, whereby free radicals such
as perhydroxyl (HO2•) and alkoxy (RO2•) are produced.




























hydroxyl radical. Oxidative stress results whenever thereFig. 5. Direct and indirect actions of radiation.
odified from Ref. [31].
Free radicals are characterized by an unpaired elec-
ron in the structure, which is very reactive and therefore
eacts with DNA molecules to cause molecular structural
amage. Hydrogen peroxide, H2O2, is also toxic to the
NA molecule. The result of the indirect action of radia-
ion on DNA molecules is the impairment of function or
eath of the cell. The number of free radicals produced
y ionizing radiation depends on the total dose. It has
een found that the majority of radiation-induced dam-
ge results from the indirect action mechanism because
ater constitutes nearly 70% of the composition of the
ell [29].
Low-LET radiations (photon) show a uniform, sparse
patial distribution of ionization in cells. High-LET par-
icles bring about a dense ionization along their track
hrough energy deposit to the medium, showing distribu-
ions called track structures. Charged-particle beams that
orm the Bragg peak in matter change the ionization den-
ity along the travelling direction, showing complexities
30] (Fig. 5).
.  DNA  damage  and  repair
The DNA molecule of a cell is the most sensitive tar-
et of radiation. The biological effects of heavy ions with
igh LET are to induce complex DNA damage, including
NA double-strand breaks (DSBs) and non-DSB clus-
ered DNA damage. Clustered lesions are defined as two
r more lesions (base damage, single strand break, abasic
ite) formed within a ∼10-bp segment by a single radia-
ion track [32]. This type of damage is difficult to repairersity for Science 10 (2016) 187–194 191
and requires coordination with more DNA repair factors
[33]. Any single unrepaired or mis-repaired DSB (Dou-
ble strand break) is adequate to induce genome instability
and promote tumourigenesis [34]. The dense core of ion-
ization along the trajectory makes heavy ion particles
have higher radiobiological effects than electromagnetic
radiation. Moreover, the DNA damages induced by its
energy deposition are DSB dominant.
When DNA DSBs occur, several DNA damage
responses will be triggered, such as cell cycle arrest,
DNA repair and apoptosis. DNA damage response incor-
porates many types of proteins because, according to
the gene code in humans, including Mre11-Rad50-Nbs1
(MRN) complex, 53BP1, BRCA1 and H2AX, each type
of protein plays different roles in different phases of
DNA damage response [35,36].
DNA double-strand breaks (DSBs) are the most dan-
gerous lesions in eukaryotic cells. If unrepairable, they
can cause cell death or carcinogenesis. One of the ear-
liest responses to DSBs caused by ionizing radiation
(IR) or by chemicals was the phosphorylation of the
core variant histone H2AX at 139-serine in megabase
chromatin domains around DSB sites with the forma-
tion of discrete nuclear H2AX foci [37]. In human
cells, the maximum induction of H2AX is observed
approximately 30–60 min after IR. Next, it is slowly
eliminated, and the kinetics of elimination correlate with
the kinetics of DSB rejoining [38]. H2AX is required
for the concentration and stabilization of DNA repair
proteins and plays a role in both non-homologous end-
joining (NHEJ) and homologous recombination (HR)
repair pathways. The ratio of DNA DSBs to visible
H2AX foci is approximately 1:1, which forms the basis
of a sensitive quantitative method for the detection of
DNA DSBs in mammalian cells [39].
8.  Radiation  protection  and  mitigation
Highly energetic heavy charged particles known as
HZE particles and protons are among the most biolog-
ically significant components of space radiation. While
there are many different types of cellular and molecu-
lar damage induced by HZE particles and protons, these
types of ionizing radiations can induce oxidative stress
in cells [40] and animals [41].
Oxidative stress is a term that describes the biological
damage of DNA, lipids and proteins by either oxygen
reactive organic radicals or oxygen radicals, e.g., theis an imbalance between the pro-oxidants and antioxi-
dants. Because the levels of oxidative stress are expected
to be higher than normal during space travel due to
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Fig. 6. Recommended terminology for therapeutic approaches to nor-
mal tissue radiation injuries.
Modified from Ref. [42].
the higher doses of radiation to which astronauts are
exposed, the use of antioxidants could possibly coun-
teract the effects of radiation-induced oxidative stress
in astronauts during space flight, thereby preventing
the downstream effects of the excessive oxidative stress
induced by radiation, such as the development of malig-
nancy. During a long-term stay in space, astronauts will
be constantly exposed to low-dose space radiation. Thus,
space radiation is one of the major health-related con-
cerns for space exploration [42].
There are three fundamental approaches to pharma-
cologic intervention (Fig. 6), and a US National Cancer
Institute Workshop [43] has recommended using differ-
ent terminology for the different approaches. Protection
or prophylaxis would refer to therapies that must begin
before the time of irradiation; a classic example is the
use of a free radical scavenger such as amifostine. Miti-
gation refers to therapies that begin after irradiation but
before there is clear evidence of clinical disease [44,45].
Treatment refers to therapies that are effective after clear
clinical disease has developed [46].
The ideal radioprotector would be one that can be
taken either before or after radiation exposure and that
would result in an increase in radiation protection, espe-
cially for late effects. It would have limited toxicity
and should be able to decrease the lifetime cancer risks
from the radiation exposure. Several different classes
of radioprotectors and mitigators are currently being
tested for use in space exploration. They can be catego-
rized by their origin as synthetic or natural compounds,
their availability as pharmaceutical drugs or nutritional
supplements, and, most importantly, according to their
molecular mechanism of action. On the molecular and
cellular levels, this classification may include (1) direct
scavengers of ROS and other free radicals, (2) anti-
oxidant agents that induce/alter endogenous levels of
ROS-detoxifying enzymes such as MnSOD, (3) agents
that enhance or modulate DNA damage signalling and
repair, and (4) agents that prevent execution of death
pathways in radiation-damaged cells. According to sev-
eral recent studies, these mechanisms are not mutually
exclusive. One radioprotective agent could exert its bio-
logical activity through one or more pathways [47].ersity for Science 10 (2016) 187–194
The effectiveness of antioxidants in space is further
complicated by the presence of HZE particles. In princi-
ple, antioxidants should provide reduced or no protection
against densely ionizing radiation because direct effect
is more important than free radical-mediated indirect
radiation damage at high-LET. However, recent experi-
ments suggest that an efficient radioprotection by dietary
supplements can be achieved even in cases of exposure
to high-LET radiation. Vitamin A strongly reduces the
induction of fibroma in rats exposed to swift Fe-ions [48].
Following exposure of human cells to accelerated high-
LET carbon ions, it has been shown that beer reduces the
yield of chromosomal aberrations. Most of the detrimen-
tal effects of heavy ions on the CNS of rats are suppressed
by dietary supplements of strawberries [49].
9.  Outlook
The biophysical and biological properties of heavy
charged particles are an attractive topic in radiotherapy
and space missions. In particle therapy, the particles
offer excellent conditions for tumour therapy, partic-
ularly for the treatment of deep-seated radio-resistant
tumours. Heavy ion particles are the concern of space-
radioprotection because the radiation spectrum of the
galactic cosmic radiation (GCR) consists of heavy
charged particles, from protons to iron ions. Astronauts
and cosmonauts aboard Low Earth Orbit (LEO) space-
craft, such as the International Space Station (ISS), are
exposed to levels of ionizing radiation far in excess of
those encountered on the ground. Large basic research
works are still needed to elucidate indications of most
of the advantages of particle therapy and to diminish the
radiation hazards present during space exploration.
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